Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-075188
Filing Date
2025-08-12
Accepted
2025-08-12 20:52:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8413
  Complete submission text file 0001213900-25-075188.txt   10162
Mailing Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065
Business Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Subject) CIK: 0001484565 (see all company filings)

EIN.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88637 | Film No.: 251208609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity Fund Holdings, L.P. (Filed by) CIK: 0001930214 (see all company filings)

EIN.: 873802421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A